Sign in
4

Changes in Ownership

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Filed Acc 0001127602-21-008123

EVP, Corp Strategy & Develop sold 8,735 shares at an average $281.70 ($2,460,615)

  • EVP, Corp Strategy & Develop acquired 2,750 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
LaPlume Joseph W EVP, Corp Strategy & Develop 2021-02-25 Option exercise +2,750 $88.05 $242,138 19,996 D
LaPlume Joseph W EVP, Corp Strategy & Develop 2021-02-25 Sale −2,012 $280.75 $564,877 17,984 D
LaPlume Joseph W EVP, Corp Strategy & Develop 2021-02-25 Sale −4,334 $281.41 $1,219,643 13,650 D
LaPlume Joseph W EVP, Corp Strategy & Develop 2021-02-25 Sale −967 $282.27 $272,951 12,683 D
LaPlume Joseph W EVP, Corp Strategy & Develop 2021-02-25 Sale −1,422 $283.50 $403,144 11,261 D
Derivatives
LaPlume Joseph W EVP, Corp Strategy & Develop 2021-02-25 Option exercise · Stock Options (Right to Buy) −2,750 743 D
Open-market sales · 8,735 sh · avg $281.70 · $2,460,615
Loading xslF345X03/form4.xml…